Harnessing Immune Response to Malignant Lung Nodules. Promise and Challenges
- PMID: 30562043
- PMCID: PMC6519851
- DOI: 10.1164/rccm.201811-2188ED
Harnessing Immune Response to Malignant Lung Nodules. Promise and Challenges
Comment on
-
Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.Am J Respir Crit Care Med. 2019 May 15;199(10):1257-1266. doi: 10.1164/rccm.201804-0628OC. Am J Respir Crit Care Med. 2019. PMID: 30422669 Free PMC article.
References
-
- Gould MK, Tang T, Liu IL, Lee J, Zheng C, Danforth KN, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192:1208–1214. - PubMed
-
- Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 2014;15:1332–1341. - PubMed
-
- Barnett PG, Ananth L, Gould MK Veterans Affairs Positron Emission Tomography Imaging in the Management of Patients with Solitary Pulmonary Nodules (VA SNAP) Cooperative Study Group. Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest. 2010;137:53–59. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
